CLinical Prediction Rule Score in Veterans

jasvinder singh

Status: Withdrawn

Conditions: Gout

Study type: Observational

Funder types: Other U.S. Federal agency; Industry

Identifiers

NCT01418781

MVAMC-3669A

Details and patient eligibility

About

We will study whether the health care costs and health utilities differ in patients with gout and those without gout and whether they differ between those with more severe versus less severe gout

Full description

The purpose of this project is to study the out-patient and inpatient utilization and costs associated with tophaceous gout (a classic form of treatment-failure gout), compare these costs to patients with non-tophaceous gout and evaluate health utilities associated with these gout states. The analyses will be conducted in a manner to support a burden of illness type of presentation / manuscript.

Study Questions

1. What are the VA health care costs (inpatient and outpatient) for patients with gout compared to those without gout?
2. Does health utility, as calculated by SF-6D, differ in patients with gout compared to patients without gout and between tophaceous and non-tophaceous gout?
3. What are the relationships between costs and health utility?
4. How does the burden of illness differ by subgroups of gout patients (costs and utilities)?
5. What are the VA health care costs for patients with tophaceous gout and are they higher than patients with non-tophaceous gout?

Inclusion criteria Patients with and without gout from the Veterans database described above will be included in the analyses for Study aims 1 and 5. This is approximately 3000 gout patients and 67,000 non-gout patients

Patients with SF-36 data from the above cohort will be included in the analyses for Study aims 2-4. This is approximately 1500 gout patients and 38,000 non-gout patients

Sex: All

Ages: 18 to 110 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• participated in the survey
• Have SF-36 adn utilization data

Exclusion criteria

• Absence of utilization and/or cost data

Trial design

0 participants in 4 patient groups

Gout

Description:

Patients with ICD-9 for gout

No Gout

Description:

Patients withOUT ICD-9 for gout

Tophaceous gout

Description:

Patients with ICD-9 for tophaceous gout

non-tophaceous gout

Description:

those with ICD-9 for gout other than the codes specific for tophaceous gout